This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Dysphagia Palliation in Esophageal Cancer

Dysphagia Palliation in Esophageal Cancer

Format

Slide Lecture Series

Time to Complete

50 minutes

Released

May 31, 2019

Expires

May 31, 2020
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM

Accredited Provider



This activity is provided by Academy for Continued Healthcare Learning.

Sponsors

This activity is sponsored by Cancer Treatment Centers of America® and ACHL.

Program Description

Expert faculty from CTCA and Banner MD Anderson recently gave a thought-provoking lecture on the management of dysphagia in patients with esophageal cancer as well as the effectiveness of emerging therapies used as monotherapy and in combination. Such insights and understandings are critical to advance patient care and optimize their health outcomes.

Intended Audience

This program is designed for oncologists, gastroenterologists, physician-trainees, pharmacists, nurses, and other allied health professionals who are involved in the care of patients with esophageal cancer.

Educational Objectives

Upon completion of this activity, participants will be able to:

  • Discuss the various modalities for management of dysphagia
  • Select the appropriate modality for management of dysphagia in patients with esophageal cancer
  • Explain the goals of palliative treatment in patients with esophageal cancer

Conflict Of Interest Disclosure Policy

ACHL requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commerical services discussed in an educational presentation and (2) with any commerical cupports of the activity. All conflicts of interest have been resolved prior to this CME/CE activity.

Faculty

Toufic Kachaamy, MD, FASGE
Gastroenterologist & Advanced Endoscopist
Gastroenterology Director, CTCA Gastrointestinal Cancer Institute
Director of Endoscopy, Interventional GI and Innovation
Cancer Treatment Centers of America®
Goodyear, AZ

Dr. Kachammy discloses the following:
Advisory Board: CSA Medical

Madappa Kundranda, MD, PhD
Director, Gastrointestinal Oncology Program
Deputy Chief, Division of Medical Oncology
Banner MD Anderson
Gilbert, AZ

Dr. Kundranda discloses the following:
Consultant: Amgen and Bayer

Accredited Provider Disclosures

ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and Cancer Treatment Centers of America (CTCA). ACHL is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM  .  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC Part II Points

Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Dysphagia Palliation in Esophageal Cancer has met the requirements as a MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:

MOC Part II CME Activity
Anesthesiology
Family Medicine
Physical Medicine and Rehabilitation
Psychiatry & Neurology
Radiology

Disclosure of Unlabeled Use

This CME/CE activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.

Discussion of Off-Label, Investigational, or Experimental Drug Use: None

Disclaimer

The content for this activity was developed independently. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher.

This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.

Instructions

This activity will take approximately 50 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity and complete the post-test and evaluation. To receive credit, 75% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.

If you have any questions relating to the accreditation of this activity, please contact:
Michelle Forcier
Senior Program Manager, ACHL
mforcier@achlcme.org

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue